It has been suggested that sintilimab combined with paclitaxel or albumin-bound paclitaxel chemotherapy may have similar clinical benefits compared to sintilimab combined with gemcitabine and platinum-based chemotherapy in patients with untreated advanced or metastatic squamous non-small cell lung cancer (17). The gene discussed is ALB; the disease is non-small cell squamous lung carcinoma.